MX2022010391A - Metodo de preparacion de derivados de amina heterociclica. - Google Patents
Metodo de preparacion de derivados de amina heterociclica.Info
- Publication number
- MX2022010391A MX2022010391A MX2022010391A MX2022010391A MX2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A
- Authority
- MX
- Mexico
- Prior art keywords
- heterocyclicamine
- derivatives
- preparation
- present
- prepared
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente divulgación se refiere a un método para preparar un derivado de amina heterocíclica, y el método de preparación según la presente divulgación tiene la ventaja de que puede prepararse un derivado de amina heterocíclica que tiene un contenido de impurezas reducido con un alto rendimiento.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200023899 | 2020-02-26 | ||
KR1020210025655A KR102531088B1 (ko) | 2020-02-26 | 2021-02-25 | 헤테로사이클릭아민 유도체의 제조 방법 |
PCT/KR2021/002440 WO2021172922A1 (ko) | 2020-02-26 | 2021-02-26 | 헤테로사이클릭아민 유도체의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022010391A true MX2022010391A (es) | 2022-09-05 |
Family
ID=77490106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022010391A MX2022010391A (es) | 2020-02-26 | 2021-02-26 | Metodo de preparacion de derivados de amina heterociclica. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230094404A1 (es) |
EP (1) | EP4112617A4 (es) |
JP (1) | JP7447291B2 (es) |
CN (1) | CN115151537B (es) |
BR (1) | BR112022016729A2 (es) |
CO (1) | CO2022011593A2 (es) |
JO (1) | JOP20220199A1 (es) |
MX (1) | MX2022010391A (es) |
WO (1) | WO2021172922A1 (es) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE318812T1 (de) | 2000-12-21 | 2006-03-15 | Bristol Myers Squibb Co | Thiazolyl-inhibitoren von tyrosinkinasen der tec- familie |
WO2005056785A2 (en) | 2003-12-05 | 2005-06-23 | Vertex Pharmaceuticals, Inc. | Crystal structure of interleukin-2 tyrosine kinase (itk) and binding pockets thereof |
WO2005066335A1 (en) | 2003-12-30 | 2005-07-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Crystal structure of the interleukin-2-inducible cell kinase (itk) kinase domain |
EP2532235A1 (en) | 2006-09-22 | 2012-12-12 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
WO2012035055A1 (en) * | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
WO2014036016A1 (en) | 2012-08-31 | 2014-03-06 | Principia Biopharma Inc. | Benzimidazole derivatives as itk inhibitors |
WO2014055934A2 (en) | 2012-10-04 | 2014-04-10 | University Of Utah Research Foundation | Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
WO2015061247A2 (en) | 2013-10-21 | 2015-04-30 | Merck Patent Gmbh | Heteroaryl compounds as btk inhibitors and uses thereof |
CN104628657A (zh) * | 2013-11-06 | 2015-05-20 | 韩冰 | 一类治疗缺血性脑损伤的化合物及其用途 |
EP3715346B1 (en) * | 2014-10-22 | 2024-01-03 | Dana-Farber Cancer Institute, Inc. | Thiazolyl-containing compounds for treating proliferative diseases |
KR102613433B1 (ko) * | 2017-10-11 | 2023-12-13 | 주식회사 대웅제약 | 신규한 페닐피리딘 유도체 및 이를 포함하는 약학 조성물 |
KR102328682B1 (ko) * | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 |
-
2021
- 2021-02-26 JO JOP/2022/0199A patent/JOP20220199A1/ar unknown
- 2021-02-26 CN CN202180015867.2A patent/CN115151537B/zh active Active
- 2021-02-26 BR BR112022016729A patent/BR112022016729A2/pt unknown
- 2021-02-26 WO PCT/KR2021/002440 patent/WO2021172922A1/ko active Application Filing
- 2021-02-26 JP JP2022551582A patent/JP7447291B2/ja active Active
- 2021-02-26 EP EP21761001.3A patent/EP4112617A4/en active Pending
- 2021-02-26 US US17/799,774 patent/US20230094404A1/en active Pending
- 2021-02-26 MX MX2022010391A patent/MX2022010391A/es unknown
-
2022
- 2022-08-17 CO CONC2022/0011593A patent/CO2022011593A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
JOP20220199A1 (ar) | 2023-01-30 |
US20230094404A1 (en) | 2023-03-30 |
JP2023515197A (ja) | 2023-04-12 |
BR112022016729A2 (pt) | 2022-10-11 |
CO2022011593A2 (es) | 2022-08-30 |
EP4112617A4 (en) | 2024-03-13 |
CN115151537B (zh) | 2024-09-06 |
JP7447291B2 (ja) | 2024-03-11 |
CN115151537A (zh) | 2022-10-04 |
EP4112617A1 (en) | 2023-01-04 |
WO2021172922A1 (ko) | 2021-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500093A1 (en) | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol | |
PH12019500493A1 (en) | Solvate form of (r)-2-amino-3-phenylpropyl carbamate | |
MX2015016947A (es) | Metodos para producir derivados de acido graso omega-hidroxilados. | |
MY197904A (en) | Method for producing substituted 5-fluoro-1h-pyrazolopyridines | |
EA201992873A1 (ru) | Получение фосфатных производных | |
EA202191502A1 (ru) | Способ получения апиксабана | |
PH12019502093A1 (en) | Novel ester compounds, method for the production thereof and use thereof | |
MX2022015151A (es) | Procesos para preparar acido 3-(3-(3,5-dimetil-1h-pirazol-4-il)pro poxi)-4- 5-fluorobenzoico (ag-10), sus compuestos intermedios, y sales del mismo. | |
MY178759A (en) | Method for preparing trichlorosilane | |
PH12019502638A1 (en) | Method for preparing intermediate of 4-methoxypyrrole derivative | |
NZ749715A (en) | Leuconostoc mesenteroides cjlm119 strain producing reduced amount of gas, and kimchi production method using same | |
MX2020006040A (es) | Intermedios para derivados de piperidina opticamente activos y procedimientos de preparacion de los mismos. | |
MX2010005015A (es) | Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero. | |
MX2022010391A (es) | Metodo de preparacion de derivados de amina heterociclica. | |
IL279168B (en) | A process for the preparation of eribulin | |
MY165659A (en) | Novel method of preparing benzoimidazole derivatives | |
WO2018196883A3 (zh) | 一种16β-甲基甾族化合物的制备方法 | |
MX2024001304A (es) | Composiciones y metodos para anticuerpos anti-pacap. | |
EA200870320A1 (ru) | Способ получения г-ксф человека | |
MX2023005954A (es) | Procesos para preparar citrato de arimoclomol e intermediarios del mismo. | |
WO2019215753A3 (en) | Process for preparation of pure plecanatide | |
WO2016079757A3 (en) | NOVEL PROCESSES FOR THE PREPARATION OF SUBSTITUTED 5-HYDROXYMETHYL-OXAZOLIDINE-2-ONE | |
MX2022004935A (es) | (+)- trans tetrahidrocannabinol ((+)-trans-thc) para uso como medicamento. | |
MX2024004579A (es) | Metodo de preparacion de derivado de benzofurano. | |
IN2014DE00737A (es) |